Showing results (341-350 of 760) with videos related to

Sort By:
Pageof 76
Cancer Letters|October 15, 2013
Targeting Mcl-1 for multiple myeloma (MM) therapy: drug-induced generation of Mcl-1 fragment Mcl-1(128-350) triggers MM cell death via c-Jun upregulationFengjuan Fan, Giovanni Tonon, Muhammad Hasan Bashari, et al.
Leukemia|April 10, 2019
Development and preclinical validation of a novel covalent ubiquitin receptor Rpn13 degrader in multiple myelomaYan Song, Paul M C Park, Lei Wu, et al.
Blood|May 22, 2016
A clinically relevant in vivo zebrafish model of human multiple myeloma to study preclinical therapeutic efficacyJianhong Lin, Weihong Zhang, Jian-Jun Zhao, et al.
Blood|September 27, 2003
Immunomodulatory drug costimulates T cells via the B7-CD28 pathwayRichard LeBlanc, Teru Hideshima, Laurence P Catley, et al.
Blood|November 16, 2002
CD40 induces human multiple myeloma cell migration via phosphatidylinositol 3-kinase/AKT/NF-kappa B signalingYu-Tzu Tai, Klaus Podar, Nicholas Mitsiades, et al.
British Journal of Haematology|May 30, 2018
Elotuzumab monotherapy in patients with smouldering multiple myeloma: a phase 2 studySundar Jagannath, Jacob Laubach, Ellice Wong, et al.
Blood|March 10, 2009
Biologic sequelae of I{kappa}B kinase (IKK) inhibition in multiple myeloma: therapeutic implicationsTeru Hideshima, Dharminder Chauhan, Tanyel Kiziltepe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivoTeru Hideshima, Paola Neri, Pierfranchesco Tassone, et al.
Cancer|February 4, 2005
Bortezomib in recurrent and/or refractory multiple myeloma. Initial clinical experience in patients with impared renal functionSundar Jagannath, Bart Barlogie, James R Berenson, et al.
Plos One|July 14, 2011
Microenvironmental influence on pre-clinical activity of polo-like kinase inhibition in multiple myeloma: implications for clinical translationDouglas W McMillin, Jake Delmore, Joseph Negri, et al.
Pageof 76